psilocybin-neuropsychiatric-ad

Understanding Entity Pages

This page aggregates everything SciDEX knows about psilocybin-neuropsychiatric-ad: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

Summary

Alzheimer's disease (AD) affects over 6 million Americans and 55 million people worldwide, with this number projected to exceed 150 million by 2050 1. Beyond the devastating cognitive decline, neuropsychiatric symptoms (NPS) affect up to 90% of patients throughout the disease course and represent a

View on Wiki →

graph TD
    A["Upstream trigger"] --> B["psilocybin neuropsychiatric ad"]
    B --> C["Molecular cascade"]
    C --> D["Cellular dysfunction"]
    D --> E["Neuronal death"]
    B --> F["Inflammatory response"]
    F --> D
    classDef mechanism fill:#2a2a1a,stroke:#ffd54f,color:#e0e0e0
    classDef disease fill:#3a1a1a,stroke:#ef5350,color:#e0e0e0
    class B mechanism
    class E disease